Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cornea|February 25, 2026
Clinical Outcomes of Pars Plana Vitrectomy in Boston Keratoprosthesis Type I in Pediatric PatientsKevin Shan, Lorena A Montalvo-Toledo, Eric Zhu, et al.
Obesity (Silver Spring, Md.)|June 13, 2009
Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapyEric Ravussin, Steven R Smith, Julie A Mitchell, et al.
Geroscience|April 29, 2025
Associations of cardiorespiratory fitness with brain white matter microstructural integrity and white matter hyperintensity volume across the adult lifespanJunyeon Won, Takashi Tarumi, Tsubasa Tomoto, et al.
Postgraduate Medicine|June 11, 2013
Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapyKathrin Herrmann, Juan P Frias, Steven V Edelman, et al.
Journal of Multidisciplinary Healthcare|February 12, 2024
Training Medical Student Counselors for the Rochester Model, a Hospital Tobacco Treatment ProgramJohn C Grable, Kevin Shan, Matthew Wang, et al.
AJNR. American Journal of Neuroradiology|August 16, 2024
Dynamic Expansion and Contraction of Multiple Sclerosis T2-Weighted Hyperintense Lesions Are Present below the Threshold of Visual PerceptionDarin T Okuda, Tatum M Moog, Morgan McCreary, et al.
Multiple Sclerosis and Related Disorders|August 15, 2024
Generative artificial intelligence versus clinicians: Who diagnoses multiple sclerosis faster and with greater accuracy?Mahi A Patel, Francisco Villalobos, Kevin Shan, et al.
Journal of the Neurological Sciences|December 29, 2024
Faster and better than a physician?: Assessing diagnostic proficiency of ChatGPT in misdiagnosed individuals with neuromyelitis optica spectrum disorderKevin Shan, Mahi A Patel, Morgan McCreary, et al.
Lancet (London, England)|March 5, 2023
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studiesWilliam J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|June 15, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 TrialsSéverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, et al.
Pageof 2